Research

Dr Jim Whittle & Prof Misty Jenkins, our Co-Heads Research Strategy & WEHI Lab Heads awarded a $2.5 million ACRF grant to launch the BRAIINSTORM program – a landmark national initiative that will fast track new personalised treatments for high grade gliomas, the most aggressive and deadly brain cancers.

Victorian researchers have made a global breakthrough, uncovering unprecedented insights into how a new drug can slow the growth of low-grade gliomas (LGG) — a type of brain cancer that mostly affects young adults.

An experimental treatment for an aggressive and lethal brain cancer has been published in Nature Medicine, paving the way for a clinical trial to be conducted by researchers at The Brain Cancer Centre. 

Researchers at WEHI have identified a promising new two-in-one treatment that not only targets and destroys an aggressive form of brain cancer, but also helps the immune system develop a lasting defence against it.

Researchers at WEHI have identified a promising new two-in-one treatment that not only targets and destroys an aggressive form of brain cancer, but also helps the immune system develop a lasting defence against it.